Quantifying the impact of novel metastatic cancer therapies on health inequalities in survival outcomes
Background: Novel therapies in metastatic cancers have contributed to improvements in survival outcomes, yet real-world data suggest that improvements may be mainly driven by those patient groups who already had the highest survival outcomes. This study aimed to develop and apply a framework for qua...
Saved in:
Main Authors: | Karolina Zebrowska (Author), Rosa C. Banuelos (Author), Evelyn J. Rizzo (Author), Kathy W. Belk (Author), Gary Schneider (Author), Koen Degeling (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Quantifying unquantifiable: The outcome of a clinical case must be quantified to make it Successful
by: Ephraim Suhir
Published: (2020) -
Sociodemographic, clinical and survival profile of adult metastatic patients
by: Vanessa Kelly Cardoso Estumano, et al.
Published: (2023) -
A new method to quantify the effect of co-medication on the efficacy of abiraterone in metastatic castration-resistant prostate cancer patients
by: Bertalan Fekete, et al.
Published: (2023) -
A novel nomogram and prognostic factor for metastatic renal cell carcinoma survival in the era of immune checkpoint inhibitors (ICIs)
by: Mohammed Alradhi, et al.
Published: (2023) -
Learning to Quantify
by: Esuli, Andrea
Published: (2023)